The Journal of Urology
Volume 186, Issue 2 , Pages 540-544, August 2011

Prevalence of Symptoms of Bladder Pain Syndrome/Interstitial Cystitis Among Adult Females in the United States

  • Sandra H. Berry

      Affiliations

    • RAND Corporation, Santa Monica, California
    • Corresponding Author InformationCorrespondence: RAND Corporation, 1776 Main St., Santa Monica, California 90407-2138 (telephone: 310-393-0411 x7779; FAX: 310-260-8013)
  • ,
  • Marc N. Elliott

      Affiliations

    • RAND Corporation, Santa Monica, California
  • ,
  • Marika Suttorp

      Affiliations

    • RAND Corporation, Santa Monica, California
  • ,
  • Laura M. Bogart

      Affiliations

    • RAND Corporation, Santa Monica, California
    • Children's Hospital Boston, Boston, Massachusetts
  • ,
  • Michael A. Stoto

      Affiliations

    • Georgetown University, Washington, D.C.
  • ,
  • Paul Eggers

      Affiliations

    • National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland
  • ,
  • Leroy Nyberg

      Affiliations

    • National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland
  • ,
  • J. Quentin Clemens

      Affiliations

    • University of Michigan, Ann Arbor, Michigan
    • Feinberg School of Medicine, Northwestern University, Chicago, Illinois
    • Financial interest and/or other relationship with Merck, Medtronic, Lilly, Pfizer and Afferent Pharmaceuticals Inc.

Received 10 December 2010 published online 16 June 2011.

Purpose

Bladder pain syndrome/interstitial cystitis is a poorly understood condition that can cause serious disability. We provide the first population based symptom prevalence estimate to our knowledge among United States adult females.

Materials and Methods

We developed and validated 2 case definitions to identify bladder pain syndrome/interstitial cystitis symptoms. Beginning in August 2007 we telephoned United States households, seeking adult women with bladder symptoms or a bladder pain syndrome/interstitial cystitis diagnosis. Second stage screening identified those subjects who met case definition criteria. Each completed a 60-minute interview on the severity and impact of bladder symptoms, health care seeking and demographics. Data collection ended in April 2009. Using population and nonresponse weights we calculated prevalence estimates based on definitions spanning a range of sensitivity and specificity. We used United States Census counts to estimate the number of affected women in 2006. The random sample included 146,231 households, of which 131,691 included an adult female. Of these households 32,474 reported an adult female with bladder symptoms or diagnosis, of which 12,752 completed the questionnaire.

Results

Based on the high sensitivity definition 6.53% (95% CI 6.28, 6.79) of women met symptom criteria. Based on the high specificity definition 2.70% (95% CI 2.53, 2.86) of women met the criteria. These percentages translated into 3.3 to 7.9 million United States women 18 years old or older with bladder pain syndrome/interstitial cystitis symptoms. Symptom severity and impact were comparable to those of adult women with established diagnoses. However, only 9.7% of the women reported being assigned a bladder pain syndrome/interstitial cystitis diagnosis.

Conclusions

Bladder pain syndrome/interstitial cystitis symptoms are widespread among United States women and associated with considerable disability. These results suggest bladder pain syndrome/interstitial cystitis may be underdiagnosed.

Key Words:  cystitis , interstitial , cross-sectional studies , prevalence , urinary bladder

Abbreviations and Acronyms:  BPS/IC, bladder pain syndrome/interstitial cystitis , ICPI, Interstitial Cystitis Problem Index , ICSI, Interstitial Cystitis Symptom Index , ORC, Opinion Research Corporation , RICE, RAND Interstitial Cystitis Epidemiology , SF-36, Medical Outcomes Study Short Form-36

 

 Supported by Cooperative Agreement U01DK070234-01 from the National Institute of Diabetes and Digestive and Kidney Disorders. National Institute of Diabetes and Digestive and Kidney Disorders staff participated in study design and analysis. Research protocol approved by the Human Subjects Protection Committee (FWA00003425). The authors vouch for the accuracy and completeness of the reported findings.

PII: S0022-5347(11)03545-2

doi:10.1016/j.juro.2011.03.132

The Journal of Urology
Volume 186, Issue 2 , Pages 540-544, August 2011